Morbidity and mortality patterns of thalassaemia major patients in Hong Kong: Retrospective study

Hong Kong Medical Journal

Volumn 8, Issue 4, 2002, Pages 255-260

  Li, C K ^a,c   Luk, C W ^b   Ling, S C ^c   Chik, K W ^a   Yuen, H L ^b   Shing, M M K ^a   Chang, K O ^b   Yuen, P M P ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^c PRINCESS MARGARET HOSPITAL   (Hong Kong)

Author keywords

Beta thalassemia; Morbidity; Mortality

Indexed keywords

DEFEROXAMINE; HORMONE;

ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CARDIOMYOPATHY; CHILD; COHORT ANALYSIS; DELAYED PUBERTY; DIABETES MELLITUS; ENDOCRINE DISEASE; FEMALE; GONADAL DISEASE; HONG KONG; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; RETROSPECTIVE STUDY; SCORING SYSTEM; SHORT STATURE; SURVIVAL; THALASSEMIA MAJOR; AGE; BETA THALASSEMIA; COMPARATIVE STUDY; INFANT; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGE FACTORS; BETA-THALASSEMIA; CHILD; CHILD, PRESCHOOL; COMPARATIVE STUDY; FEMALE; HONG KONG; HUMAN; INFANT; MALE; MORBIDITY; RETROSPECTIVE STUDIES; HUMANS;

EID: 0036023240     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Prevalence and genotypes of alpha- and beta-thalassemia carriers in Hong Kong - Implications for population screening
2. Treatment of hemoglobin Bart's hydrops with bone marrow transplantation
3. Survival and desferrioxamine in thalassaemia major
4. Stem cell transplant for thalassaemia patients in Hong Kong
5. Desferrioxamine-induced long bone changes in thalassaemic patients-radiographic features, prevalence and relations with growth
6. Deferoxamine-induced bone dysplasia in the distal femur and patella of pediatric patients and young adults: MR imaging appearance
7. Iron storage disease
8. Survival in medically treated patients with homozygous beta-thalassemia
9. Survival and causes of death in thalassaemia major
10. Survival in beta-thalassaemia major in the UK: Data from the UK Thalassaemia Register
11. Safety profile of the oral iron chelator deferiprone: A multicentre study
12. Multicentre study on prevalence of endocrine complications in thalassaemia major
13. Effect of age at the start of iron chelation therapy on gonadal function in beta-thalassemia major
14. Deferoxamine-induced growth retardation in patients with thalassemia major
15. Growth failure and bony changes induced by deferoxamine
16. Short stature in homozygous beta-thalassaemia is due to disproportionate truncal shortening
17. Final height and body disproportion in thalassaemic boys and girls with spontaneous or induced puberty
18. Klebsiella pneumoniae meningitis in thalassemia major patients
19. Transfusion-related immunomodulation in Chinese children with thalassaemia
20. Bone marrow transplantation in patients with thalassemia
21. Bone marrow transplantation from alternative donors for thalassemia: HLA-phenotypically identical relative and HLA-nonidentical sibling or parent transplants